External validation of the 2007 and 2001 Partin tables in Irish prostate cancer patients

Urologia Internationalis

Volumn 84, Issue 2, 2010, Pages 174-179

  Fanning, D M ^a   Fan, Y ^a   Fitzpatrick, J M ^b   Watson, R W G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Prostate cancer; Prostatectomy; Tumor staging

Indexed keywords

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER INVASION; CANCER PATIENT; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PARTIN TABLE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; VALIDATION STUDY;

ADULT; AGED; AREA UNDER CURVE; COHORT STUDIES; HUMANS; IRELAND; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 77949415707     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277594     Document Type: Article

References (20)

1. Eastham JA, Scardino PT, Kattan MW: Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 2008; 179: 2207-2210.
2. Gallina A, Chun FK, Briganti A, Shariat SF, Montorsi F, Salonia A, Erbersdobler A, Rigatti P, Valiquette L, Huland H, Graefen M, Karakiewicz PI: Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. Eur Urol 2007; 52: 98-105.
3. Chun FK, Scardino PT, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M, Huland H, Graefen M, Karakiewicz PI: Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006; 49:820-826.
4. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277: 1445-1451.
5. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD: Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58: 843-848.
6. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110-114.
7. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007; 69:1095-1101.
8. Taylor JM, Ankerst DP, Andridge RR: Validation of biomarker-based risk prediction models. Clin Cancer Res 2008; 14: 5977-5983.
9. Gleason DF: Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50:125-128.
10. Trends in Irish cancer incidence 1994-2002 with projections to 2020. National Cancer Registry Ireland, 2006.
11. Health Statistics Quarterly Autumn: United Kingdom Office for National Statistics, 2000.
12. Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H: Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000; 164: 1591-1595.
13. Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ: The effect of race/ethnicity on the accuracy of the 2001 Partin tables for predicting pathologic stage of localized prostate cancer. Urology 2008;71: 151-155.
14. Ayyathurai R, Ananthakrishnan K, Rajasundaram R, Knight RJ, Toussi H, Srinivasan V: Predictive ability of Partin tables 2001 in a Welsh population. Urol Int 2006; 76: 217-222.
15. Gao X, Ren S, Lu X, Xu C, Sun Y: The newer the better? Comparison of the 1997 and 2001 Partin tables for pathologic stage prediction of prostate cancer in China. Urology 2008;72: 1096-1101.
16. Naito S, Kuroiwa K, Kinukawa N, Goto K, Koga H, Ogawa O, Murai M, Shiraishi T, Clinicopathological Research Group for Localized Prostate Cancer Investigators: Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 2008; 180: 904-909.
17. Karakiewicz PI, Bhojani N, Capitanio U, Reuther AM, Suardi N, Jeldres C, Pharand D, Péloquin F, Perrotte P, Shariat SF, Klein EA: External validation of the updated Partin tables in a cohort of North American men. J Urol 2008; 180: 898-902.
18. May M, Gunia S, Helke C, Führer S, Hoschke B, Fahlenkamp D, Vogler H, Siegsmund M: How far is the preoperative Kattan nomogram applicable for the prediction of recurrence after prostatectomy in patients presenting with PSA levels of more than 20 ng/ml? A validation study. Urol Int 2006; 77:222-226.
19. Bhojani N, Ahyai S, Graefen M, Capitanio U, Suardi N, Shariat SF, Jeldres C, Erbersdobler A, Schlomm T, Haese A, Steuber T, Heinzer H, Montorsi F, Huland H, Karakiewicz PI: Partin tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol 2009; 35: 123-128.
20. Bhojani N, Salomon L, Capitanio U, Suardi N, Shariat SF, Jeldres C, Zini L, Pharand D, Péloquin F, Arjane P, Abbou CC, De La Taille A, Montorsi F, Karakiewicz PI: External validation of the updated partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys 2009; 73: 347-352.